COLL
Collegium Pharmaceutical Inc

1,589
Mkt Cap
$1.62B
Volume
453,700.00
52W High
$50.01
52W Low
$23.23
PE Ratio
31.02
COLL Fundamentals
Price
$49.84
Prev Close
$49.58
Open
$49.77
50D MA
$43.36
Beta
0.62
Avg. Volume
643,475.74
EPS (Annual)
$1.86
P/B
5.73
Rev/Employee
$1.77M
Loading...
Loading...
News
all
press releases
Here's Why Investors Should Hold Ensign Group Stock for Now
ENSG's 23-year dividend hike streak, strong acquisitions and revenue growth bolster its long-term investment appeal.
Zacks·2d ago
News Placeholder
More News
News Placeholder
Collegium Pharmaceutical (NASDAQ:COLL) Hits New 12-Month High - Still a Buy?
Collegium Pharmaceutical (NASDAQ:COLL) Reaches New 1-Year High - What's Next...
MarketBeat·2d ago
News Placeholder
Should Value Investors Buy Collegium Pharmaceutical (COLL) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Zacks·6d ago
News Placeholder
Are Medical Stocks Lagging Actinium Pharmaceuticals (ATNM) This Year?
Here is how Actinium Pharmaceuticals (ATNM) and Collegium Pharmaceutical (COLL) have performed compared to their sector so far this year.
Zacks·6d ago
News Placeholder
Assenagon Asset Management S.A. Purchases 92,898 Shares of Collegium Pharmaceutical, Inc. $COLL
Assenagon Asset Management S.A. raised its holdings in shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL - Free Report) by 90.5% during the third quarter, according to its most recent filing with...
MarketBeat·6d ago
News Placeholder
Best Value Stocks to Buy for Dec. 18
KE, COLL and JRVR made it to the Zacks Rank #1 (Strong Buy) value stocks list on Dec. 18, 2025.
Zacks·10d ago
News Placeholder
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Receives Average Rating of "Buy" from Brokerages
Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL - Get Free Report) have been assigned a consensus recommendation of "Buy" from the seven ratings firms that are currently covering the company...
MarketBeat·11d ago
News Placeholder
Insider Selling: Collegium Pharmaceutical (NASDAQ:COLL) EVP Sells 17,600 Shares of Stock
Collegium Pharmaceutical, Inc. (NASDAQ:COLL - Get Free Report) EVP Scott Dreyer sold 17,600 shares of the firm's stock in a transaction that occurred on Monday, December 8th. The shares were sold at...
MarketBeat·17d ago
News Placeholder
MOH, Aeroflow Team Up to Offer Virtual Diabetes Care in South Carolina
Molina Healthcare partners with Aeroflow Health to expand nutrition counseling and diabetes care for the former's Commercial and Medicare members in South Carolina.
Zacks·17d ago
News Placeholder
Collegium Pharmaceutical (NASDAQ:COLL) Stock Rating Upgraded by Barclays
Barclays upgraded Collegium Pharmaceutical to a "strong-buy" rating in a report on Monday...
MarketBeat·18d ago
<
1
2
...
>

Latest COLL News

View

Advertisement|Remove ads.

Advertisement|Remove ads.